Issue with PBE Calculation when Stage = 1 [Regulatives / Guidelines]

posted by weiguo2122 – 2025-01-13 21:19 (30 d 13:58 ago) – Posting: # 24339
Views: 567

FDA “Draft Guidance on Budesonide” part 5, provides Recommendation Related to the Population Bioequivalence (PBE) Statistical Analysis Procedure (Step 3):

a. If SigmaR is greater than 0.1, the reference-scaled procedure should be used.
b. If SigmaR is less or equal to 0.1, then the constant-scaled procedure should be used.

However, when stage (m) is 1, SigmaR cannot be defined because the calculation for MSWk cannot proceed when m = 1 (see formula for MSWk in the guidance).
[image]
[image]

What approach should be used to calculate PBE when m = 1? Are there any alternative methods or approaches recommended in this scenario?

I have attached formula from Draft Guidance on Budesonide for reference.

Thanks for replying and suggesting!

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
49 visitors (0 registered, 49 guests [including 8 identified bots]).
Forum time: 11:17 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5